Primary or secondary prevention of hiv-associated histoplasmosis during the early antiretrovirals for all era

HIGHLIGHTS

• who: Mathieu Nacher et al. from the Centre have published the research: Primary or secondary prevention of HIV-associated histoplasmosis during the early antiretrovirals for all era, in the Journal: (JOURNAL) of December/30,/2022
• what: Although the study was preHAART, it showed that patients who were being treated with 3 or more antiretroviral drugs at the completion of the study were significantly less likely to have prophylaxis failure.

SUMMARY

Published February 2, 2023 February Although most studies actually concern symptomatic patients, the natural history of HIV-associated progressive disseminated histoplasmosis . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.